Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome by Abdul-Sater, Ali A et al.
Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3
inflammasome
Ali A. Abdul-Sater1w, Ivan Tattoli2, Lei Jin3z, Andrzej Grajkowski 4, Assaf Levi5, Beverly H. Koller 6,
Irving C. Allen7, Serge L. Beaucage4, Katherine A. Fitzgerald8, Jenny P.-Y. Ting7, John C. Cambier3,
Stephen E. Girardin2 & Christian Schindler1,9+
1Department of Microbiology & Immunology, Columbia University, New York, New York, USA, 2Department of Laboratory Medicine
& Pathobiology, University of Toronto, Toronto, Ontario, Canada, 3Integrated Department of Immunology, University of Colorado
Denver School of Medicine and National Jewish Health, Denver, Colorado, 4Division of Therapeutic Proteins, Center for Drug
Evaluation and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, Maryland, 5University of Chicago,
Department of Microbiology, Cummings Life Sciences Center, Chicago, Illinois, 6Department of Genetics & Lineberger
Comprehensive Cancer Center, 7Department of Microbiology-Immunology & Lineberger Comprehensive Cancer Center, Institute
of Inflammatory Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 8Division of Infectious Diseases
and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, and 9Department of Medicine, Columbia
University, New York, New York, USA
The cyclic dinucleotides 3’-5’diadenylate (c-diAMP) and 3’-5’
diguanylate (c-diGMP) are important bacterial second messen-
gers that have recently been shown to stimulate the secretion of
type I Interferons (IFN-Is) through the c-diGMP-binding protein
MPYS/STING. Here, we show that physiologically relevant levels
of cyclic dinucleotides also stimulate a robust secretion of IL-1b
through the NLRP3 inflammasome. Intriguingly, this response
is independent of MPYS/STING. Consistent with most NLRP3
inflammasome activators, the response to c-diGMP is dependent
on the mobilization of potassium and calcium ions. However, in
contrast to other NLRP3 inflammasome activators, this response
is not associated with significant changes in mitochondrial
potential or the generation of mitochondrial reactive oxygen
species. Thus, cyclic dinucleotides activate the NLRP3 inflamma-
some through a unique pathway that could have evolved to detect
pervasive bacterial pathogen-associated molecular patterns
associated with intracellular infections.
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INTRODUCTION
Eukaryotes have evolved pattern recognition receptors to recog-
nize essential molecular patterns associated with pathogens
(a.k.a., pathogen-associated molecular patterns; [1,2]). This
includes components of the inflammasome, a family of
multi-protein complexes that direct the caspase-1-dependent
activation and secretion of IL-1b and IL-18 (reviewed in [3–6]).
Inflammasomes distinguish themselves from other innate
responses by requiring two signals to become activated. The first
signal entails the PRR- and NF-kB-dependent expression of pro-
IL-1b and pro-IL-18, whereas the second signal involves a distinct
PAMP-dependent activation of the inflammasome. The adaptor
protein ASC (apoptosis speck-like protein with CARD), a critical
component of many inflammasomes, facilitates the interaction
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between the presumed PAMP ‘sensing’ component of each
inflammasome and caspase-1. Sensing components are unique
to each inflammasome and include NLRP1b, NLRP3, NLRC4
and AIM2.
The NLRP3 inflammasome has been studied most extensively
because of its association with human disease and its response to
divergent ‘molecular patterns’. These include molecules associated
with tissue damage (for example, monosodium urate; (MSU)
and ATP) and environmental stressors (for example, crystalline
silica, asbestos, alum, b-amyloid, nigericin and cholesterol;
reviewed in [3–5]). Efforts to understand how these pleiotropic
ligands promote NLRP3 inflammasome activation have implicated
sequential mobilization of potassium (Kþ ) and calcium (Caþþ )
ions [7–10]. This mobilization also appears to be associated with
mitochondrial stress, notably including decreased mitochondrial
membrane potential (Dcm), increased mitochondrial reactive
oxygen species (mROS) production and the cytosolic
accumulation of oxidized mitochondrial (mt)DNA. Recently,
studies have championed oxidized mtDNA and MAVS
(mitochondrial antiviral signaling protein) as final common
mediators of NLRP3 inflammasome activation [7,9,11–14]. In
contrast, however, the ability of other microbial pathogen-
associated molecular patterns, like poly(dA:dT), flagellin and
Bacillus anthracis lethal toxin to promote inflammasome
activation appears to involve a direct interaction between these
‘ligands’ and AIM2, NLRC4 and NLRP1b, respectively [4,15–18].
Studies exploring the ability of Legionella pneumophila to
stimulate IL-1b secretion in infected macrophages determined that
flagellin activates the Naip5-NLRC4 inflammasome [19]. Another
L. pneumophila PAMP, cyclic 30-50 diguanylate (c-diGMP), an
important bacterial second messenger [20], was identified as the
critical PAMP stimulating activation of the IFN-a/b axis [21,22].
Intriguingly, closely related cyclic 30-50diadenylate (c-diAMP)
was also found to direct IFN-a/b expression, during a Listeria
monocytogenes infection [23]. Subsequently, MPYS/STING,
previously implicated in DNA-dependent IFN-a/b induction [24],
was found to bind and direct the type I IFN (IFN-I) response to
cyclic dinucleotides [24–28]. Yet, MPYS/STING exhibits a
relatively broad pattern of expression, suggesting a role for
a more tissue-restricted component in this response, such as
DDX41 [29] or cyclic GMP-AMP Synthase [28].
Evidence that poly(dA:dT) stimulates the production of IFN-I
and IL-1b through distinct pattern recognition receptors [6,30]
raised the possibility that the ability of c-diGMP to stimulate the
expression of these two cytokines might also be mediated through
multiple receptors [31]. Consistent with this, c-diAMP and
c-diGMP were found to robustly stimulate inflammasome
activity in human and murine macrophages. This response was
dependent on NLRP3, as well as Kþ and Caþþ mobilization.
More importantly, this response was not associated with mROS
production or a loss in Dcm, two events recently implicated as a
common component of NLRP3 inflammasome activation. Thus,
cyclic dinucleotides activate the NLRP3 inflammasome in
macrophages through a distinct pathway, one that is also
independent of MPYS/STING.
RESULTS AND DISCUSSION
Cyclic-dinucleotides activate IL-1b secretion
Consistent with previous studies, immunoblotting and ELISA
confirmed that stimulation of LPS-pretreated murine bone
marrow-derived macrophages (BMMs) or PMA-pretreated human
THP-1 cells with ATP, a canonical NLRP3 ligand, led to a marked
increase in secretion of activated caspase-1 (p10 and p20,
respectively) and IL-1b (that is, p17 kDa; see Fig 1A and
supplementary Fig S1A online; [4,8,32]). Likewise, transfection
of poly(dA:dT), an AIM2 ligand, led to equivalent increases in
secreted caspase-1 and IL-1b (Fig 1A). Remarkably, transfection of
c-diGMP or c-diAMP, at doses previously shown to promote
MPYS/STING-dependent IFNb expression [21,22], was associated
with an analogous robust and dose-dependent increase in
caspase-1 and IL-1b production (Fig 1B). Importantly, these doses








































































































Fig 1 | Cyclic dinucleotides activate the inflammasome in THP-1 cells and murine BMMs. (A) PMA-differentiated THP-1 cells (left panel) were treated
with ATP (5 mM; 6 h) or transfected (Lipofectamine 2000; lpftm) with c-diGMP (cdG; 5 nmol; 6 h) or poly(dA:dT) (dA:dT; 5 mg/ml; 6 h). LPS-primed
BMMs (right panel) were treated with ATP (5 mM; 6 h) or transfected (X-tremegene HP; Xtrm) with c-diGMP (10 nmol; 6 h), c-diAMP (10 nmol; 6 h),
cGMP (10 nmol; 6 h) or GTP (10 nmol; 6 h). Supernatants were immunoblotted for immature IL-1b (pro-IL1b), active IL-1b (p17), immature caspase-1
(pro-Cas1) or active caspase-1 (Cas1, p20 and p10, respectively). (B) IL-1b levels were measured by ELISA (BD Biosciences) in 6 h supernatants of
LPS-primed BMMs after the indicated treatment with c-diGMP or c-diAMP, as in A. (C) IL-1b levels were measured by ELISA in BMMs infected
with IPTG-induced L. pneumophila strains (MOI 10; 6 h), ectopically expressing cdgS3, cdgS3B or cdgS4 [35]. Graphs present means±standard error
from three independent experiments. BMMs, bone marrow-derived macrophages; c-diAMP, 30-50 diadenylate; c-diGMP, 30-50 diguanylate; ELISA,
enzyme-linked immunosorbent assay; MOI, multiplicity of infection.
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stimulate the AIM2 inflammasome [33,34]. As previously
reported, c-diGMP appeared to show more potent activity than
c-diAMP [21,23]. Of note, control treatments with other guanine
nucleotides (for example, cGMP and GTP), as well as transfection
reagents alone (that is, Lipofectamine and X-tremegene), failed to
induce IL-1b secretion (Fig 1A and supplementary Fig S1A online).
These results demonstrate that cyclic dinucleotides potently
stimulate the inflammasome.
To explore a physiological role for c-diGMP in inflammasome
activation, L. pneumophila cdgS strains previously exploited
to identify a role for c-diGMP in IFN-I induction, were
evaluated [21,35]. Specifically, these studies examined
L. pneumophila strains ectopically expressing: cdgS4 (lpg0156), a
phosphodiesterase associated with greater than threefold reduction
in c-diGMP levels (that is, from 8.3 to 2.4 fmol/OD of bacteria);
cdgS3 (lpg0155), a diguanylate cyclase associated with greater
than threefold increase c-diGMP levels (that is, from 8.3 to 24 fmol/
OD); and cdgS3B, a point mutant that is resistant to c-diGMP
feedback inhibition [35]. Of note, these measured dinucleotide
levels correspond closely with endogenous levels of c-diAMP
previously reported for intracellular Listeria monocytogenes
infection [23]. Additionally, as L. pneumophila flagellin is also
known to activate the Naip5-NLRC4 inflammasome [36], it
was important to carry out these studies in flagellin-deficient
strains. As expected, loss of flagellin led to an approximately
two-fold reduction in IL-1b secretion (see Fig 1C). Consistent with
changes in c-diGMP levels, IL-1b secretion was significantly
increased in BMMs infected with the flagellin null L. pneumophila
ectopically expressing cdgS3 or cdgS3B. However, the reduction
in IL-1b secretion in L. pneumophila ectopically expressing cdgS4
was not significant (Fig 1C; [35]).
c-diGMP stimulates cation mobilization
Recent studies have revealed that the ability of divergent ligands
to activate the NLRP3 inflammasome is dependent on cation
mobilization (that is, Kþ and Caþþ ; [7,8,10,37]). To determine
whether this might also be the case for cyclic dinucleotides,
BMMs were treated with inhibitors of Kþ mobilization (that is,
KCl and glibenclamide) or Caþþ mobilization (that is, 2-ABP
and U73122) before stimulation with c-diGMP and other well-
characterized NLRP3 inflammasome activators. Consistent with
prior reports, the ability of ATP, MSU and silica, as well as alum
and nigericin (see supplementary Fig S1B online), to stimulate
NLRP3 inflammasome activation was sensitive to each of these
inhibitors (Fig 2A; [7]). Likewise, stimulation with transfected
c-diGMP and c-diAMP was also sensitive to all four inhibitors,
underscoring an important mechanistic overlap with known
NLRP3 inflammasome activators (Fig 2A; [7,8]). In contrast,
stimulation with Salmonella typhimurium, which activates both
the NLRP3 and NLRC4 inflammasomes, was unexpectedly most
sensitive to inhibition of Caþþ mobilization [38], whereas
poly(dA:dT)-stimulated AIM2 inflammasome activation was
uniquely sensitive to extracellular KCl (Fig 2A; [6,34,38]). This
latter observation raised the possibility that more than one Kþ
channel might be involved in this response [8], and suggested
that cations might have a more complicated and pervasive role in
inflammasome activation than previously anticipated. Finally,
despite their ability to block inflammasome activation, these
inhibitors failed to impede c-diGMP- and poly(dA:dT)-dependent
IFN-b expression, drawing attention to important functional
distinction between these responses (Fig 2B; [21,22,26,30]).
c-diGMP activates the NLRP3 inflammasome
To more rigorously investigate the role of the NLRP3 inflamma-
some in the innate response to cyclic dinucleotides, macrophages
defective in specific inflammasome components were evaluated.
As anticipated, ATP failed to activate the inflammasome in BMMs
prepared from NLRP3[ / ] and ASC[ / ] mice, whereas
poly(dA:dT)-dependent inflammasome activity was defective in
ASC[ / ] and AIM2[ / ] macrophages (see Fig 3A;
supplementary Fig S2A,B online). Notably, the ability of c-diGMP
to stimulate capase-1 and IL-1b activation was abrogated in
NLRP3[ / ] and ASC[ / ] BMMs, but not NLRC4[ / ],
AIM2[ / ] or NLRP1b[ / ] BMMs, which are defective in
their response to flagellin, poly(dA:dT) and B. anthracis lethal
toxin (LT; [16–18]), respectively (see Fig 3A, supplementary
Fig S2A–C online). As previously reported, when these culture
supernatants were assayed for IL-18, there was a parallel, but less
robust accumulation of this cytokine (see supplementary Fig S2E
online; [39,40]). Intriguingly, LT-stimulated IL-18 production was
proportionately more robust. Although discordance between IL-1b
and IL-18 production has been previously reported, the
mechanism has not been fully elucidated [41].
Again, c-diGMP-stimulated IFN-b expression was not affected
by the loss of NLRP3, NLRC4 or ASC (Fig 3B), underscoring
essential differences in these two inflammatory responses.
A parallel set of studies, examining THP-1 cells knocked down
for NLRP3 or ASC expression (supplementary Fig S2F online),
revealed the same pattern of inhibition (Fig 3C; [32]).
Reassuringly, the responses to ATP, poly(dA:dT) and c-diGMP
were fully restored in ASC knockdown cells expressing an short
hairpin RNA resistant ASC cDNA (that is, shASCmut; Fig 3C;
supplementary Fig S2F online). Consistent with a dependence on
cation mobilization, these genetic studies provide compelling
evidence that c-diGMP activates the NLRP3 inflammasome.
Recent studies have implicated several additional components
in the regulation of the NLRP3 inflammasome, including a pivotal
role for mitochondrial stress [7,11–13,42–44]. To explore whether
cyclic dinucleotide-dependent inflammasome activation was also
associated with mitochondrial stress, c-diGMP-stimulated BMMs
were stained with mitoSox to measure mROS production and
tetramethyl rhodamine methyl ester (TMRM) to evaluate Dcm.
Consistent with previous studies, ATP stimulation led to a
significant increase in mitoSox staining (that is, mROS
production; see supplementary Fig S3A,B online) and a notable
decrease in TMRM incorporation (that is, Dcm; supplementary
Fig S3C–E online; [7,11–13]). As expected, the AIM2-dependent
response to poly(dA:dT) was neither associated with changes in
mitoSox staining (supplementary Fig.S3A,B online) nor TMRM
incorporation (supplementary Fig S3C–E online). Intriguingly,
stimulation with c-diGMP was also not associated with any
significant changes in either mitoSox or TMRM staining
(supplementary Fig S3A–E online). Consistent with recent
reports, there was also no evidence that cyclic dinucleotide-
stimulated inflammasome activation was associated with the
double-stranded RNA kinase PKR or HMBG1 release (see
supplementary Figs S2D and S4A online; data not shown; [45]).
Finally, studies with an inhibitor of BRCC3, a deubiquitinase
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implicated in NLRP3 inflammasome activation, revealed the
anticipated defect in response to ATP (supplementary Fig S4B
online; [42]). This inhibitor also blocked the ability of cyclic
dinucleotides to activate the inflammasome, suggesting that
BRCC3 broadly regulates NLRP3 inflammasome activation. These
observations are consistent with the notion that c-diGMP-directed
NLRP3 inflammasome activation is dependent on BRCC3-mediated
deubiquitinylation, but independent of mitochondrial perturbation.
Inflammasome activation is independent of STING
MPYS/STING has been identified as a critical component in
cyclic dinucleotide-stimulated IFN-I expression [25–27]. To
explore whether this receptor has a similar role in cyclic
dinucleotide-stimulated inflammasome activation, BMMs were
prepared from MPYS/STING knockout mice [25]. Intriguingly,
analogous to poly(dA:dT)-dependent IL-1b and caspase-1
activation, MPYS/STING was not required for the response
to c-diGMP (Fig 4A; [6,24,30]). Yet, as previously reported,
c-diGMP and poly(dA:dT)-stimulated IFN-b expression were
highly dependent on MPYS/STING, whereas the response to
poly(I:C) was MPYS/STING independent (Fig 4B; [24,30]). These
observations, as well as the lack of correlation between the
cellular expression of MPYS/STING and c-diGMP response, raised
the possibility that an unknown PRR both senses and directs the
ability of c-diGMP to activate the NLRP3 inflammasome [46].
Subsequent studies explored the ability of c-diGMP to stimulate
inflammasome activation in vivo, absent priming (that is, signal 1),
as has previously been reported for MSU, silica, alum and
hemozoin [47–50]. Peritoneal instillation of c-diGMP was
associated with a robust accumulation of leukocytes (PMNs and
macrophages) in wild-type mice (Fig 4C; supplementary Fig S5A
online [31]). As anticipated, pretreatment of mice with an IL-1b
blocking antibody prevented this response (supplementary Fig S5B
online). Consistent with our in vitro analysis, the IL-1b-mediated
recruitment of leukocytes was dependent on NLRP3. Even though






































































































































































































































Fig 2 | Cation mobilization during c-diGMP NLRP3 inflammasome activation.(A) IL-1b levels were measured by ELISA in LPS-primed BMMs treated
with KCl (130 mM), Glibenclamide (Gli; 50 mM), 2-APB (100mM) or U73122 (10mM) 30 min before stimulation with ATP (5 mM; 30 min), MSU
(100mg/ml; 4 h) and silica (500mg/ml, 6 h); or transfection with c-diGMP (10 nmol; 6 h), c-diAMP (10 nmol; 6 h) and poly(dA:dT) (5 mg/ml; 6 h); or
infected with S. typhimurium (MOI 25; 6 h). (B) IFN-b expression was evaluated by Q–PCR in LPS-primed BMMs treated as in panel A. Results were
normalized to GAPDH and reported as relative fold change. Graphs present means±standard error from three independent experiments. BMMs, bone
marrow-derived macrophages; c-diAMP, 30-50 diadenylate; c-diGMP, 30-50 diguanylate; ELISA, enzyme-linked immunosorbent assay; GAPDH,
Glyceraldehyde-3-phosphate dehydrogenase; IFN-b, interferon beta; MOI, multiplicity of infection; Q–PCR, quantitative polymerase chain reaction.
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Fig 3 | c-diGMP-stimulated inflammasome activation is dependent on
NLRP3. (A) Secreted IL-1b and Cas1 levels were evaluated by
immunoblotting in LPS-primed WT, NLRP3 / , NLRC4 / or
ASC / BMMs, as in Fig 1. (B) IFN-b and GAPDH expression were
evaluated by PCR, in BMMs treated as in panel A. (C) Secreted IL-1b
and caspase-1 levels were evaluated in PMA-differentiated THP-1 cells
stably expressing control shRNA (shCtrl), shNLRP3, shASC or the re-
expression of a knockdown resistant ASC cDNA (shASCmut), as above.
Data are representative of more than three independent experiments.
ASC, apoptosis speck-like protein with CARD; BMMs, bone marrow-
derived macrophages; Cas1, caspase-1; c-diGMP, 30-50 diguanylate; IFN-b,
interferon beta; IL-1b, interleukin 1 beta; GAPDH, Glyceraldehyde-3-
phosphate dehydrogenase; PCR, polymerase chain reaction; shctrl,
control short hairpin RNA; WT, wild type.










































































Fig 4 | c-diGMP-stimulated inflammasome activation is independent of
MPYS/STING. (A) Secreted IL-1b and Cas1 were evaluated in LPS-primed
WT* or MPYS/STING[ / ] BMMs, as in Fig 1. *(Note, the WT data
(right panel) is a replicate of WT data presented in Fig 3A.) (B) IFN-b
expression was evaluated by Q–PCR in WT or MPYS/STING[ / ] BMMs
6 h after transfection with c-diGMP (cdG; 10 nmol), poly(I:C) (I:C; 1mg/ml)
or poly(dA:dT) (dA:dT; 1mg/ml) as in Fig 2. Results are reported as
relative log fold change with respect to untreated controls and graphed as
means±standard error from three independent experiments. (C) Peritoneal
leukocytes were enumerated by FACS (see supplementary Fig S5A,B
online) 15 hrs after IP injection of PBS or c-diGMP (cdG; 160 nmols). The
scatter plot represents data from two independent experiments (n¼ 6 mice
for c-di-GMP and n¼ 4 mice for PBS treatment). Statistical significance
was evaluated by student’s t-test (Graphpad). BMMs, bone marrow-derived
macrophages; Cas1, caspase-1; c-diGMP, 30-50 diguanylate; FACS,
fluorescence-activated cell sorting; IP, intraperitoneal; IFN-b, interferon
beta; IL-1b, interleukin 1 beta; PBS, phosphate-buffered saline;
PCR, polymerase chain reaction; WT, wild type.
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loss of MPYS/STING, a more detailed analysis revealed that this
was associated with an altered distribution in accumulating
leukocytes (Fig 4C; supplementary Fig S5A online). The recruit-
ment of PMNs was significantly reduced, likely reflecting a loss in
IL-1b production. These findings suggest that MPYS/STING
functions upstream of NLRP3 in vivo. This contrasts our
observations in cultured macrophages in which both signal 1
(that is, PRR-dependent NF-kB activation) and signal 2 (that is,
c-diGMP, ATP, nigericin, MSU, poly(dA:dT), and so on)
were required to activate the inflammasome independently of
MPYS/STING. Consistent with its response in vivo, MPYS/STING is
required for c-diGMP-induced canonical NF-kB activation in
myeloid cells (signal 1) (Jin Lei, manuscript in preparation). These
observations implicate STING in a c-diGMP-dependent activation
of NF-kB and might explain why NLRP3 ‘ligands’ are able to
direct inflammasome activation in vivo absent signal 1.
In summary, these studies demonstrate that in addition to their
ability to induce IFN-I expression through an interaction with
MPYS/STING [21,22,26,27], cyclic dinucleotides also activate the
NLRP3 inflammasome at levels corresponding to those observed
during an intracellular bacterial infection [23,35]. Analogous to
other NLRP3 stimulating agents, the response to cyclic
dinucleotides was dependent on Kþ and Caþþ mobilization,
as well as the BRCC3 deubiquitinase. Surprisingly, the c-diGMP-
stimulated inflammasome activation was neither associated with a
loss in Dcm nor with increases in mROS production, as has
recently been reported for other NLRP3 ‘triggers’ [10]. These
observations exclude a significant role for mitochondrial damage
during c-diGMP-dependent inflammasome activation and suggest
this response is also likely to be independent of mitochondrial
antiviral signalling protein [14]. Equally remarkable, in vitro
cyclic dinucleotide-stimulated inflammasome activation was
found to be independent of MPYS/STING, revealing that a
distinct, unknown host receptor is directing the ability of cyclic
dinucleotides to provide signal 2 for inflammasome activation.
This receptor may also participate in other c-diGMP-stimulated
responses [22,25]. Although, preliminary studies have largely
excluded a role for GBP5 in the response to cyclic dinucleotides
(data not shown; [46]), it will be interesting to explore whether
NLRP3 itself or DDX41 contribute to this response [29]. These
observations suggest that mammals evolved at least two
distinct innate responses to bacterial-delivered c-diGMP, one
that promotes the IL-1b-dependent recruitment of inflammatory
cells [50,51], and another that entails IFN-I and potentially
NF-kB-dependent activation of these immune cells. This intriguing
dichotomy will be an important area of future investigation.
METHODS
Cell culture. THP-1 cells were cultured as previously reported [21].
ASC (shASC), NLRP3 (shNLRP3) knockdown and ASC
re-expressing (shASCmut) THP-1 lines were previously
characterized [32]. Primary bone marrow-derived macrophages
(BMMs) were prepared from 129, C57Bl6/J, NLRP3[ / ],
NLRC4[ / ], ASC[ / ], MPYS/STING[ / ], AIM2[ / ]
and NLRP1b[ / ] mice [17,25,40,52], as previously
reported [21]. In some studies, cells were treated with inhibitors
of Kþ efflux (that is, KCl; or Glibenclamide, Sigma-Aldrich,
St Louis, MO) or Caþþ mobilization (that is, phospholipase C
inhibitor U73122, Sigma-Aldrich; or store-operated Ca2þ entry
channel inhibitor 2-aminoethoxydiphenyl borate, 2-APB,
Sigma-Aldrich). RT and Q–PCR were preformed as previously
reported ([21]; see Supplementary Table S1 online for primers). All
murine studies were IACUC approved (see supplementary
Materials and methods online section for additional details).
Inflammasome stimulation. THP-1 cells were primed with phor-
bol myristate acetate (PMA; 100 nM, over night; Sigma-Aldrich) and
BMMs were primed with LPS (1mg/ml, 3 h; E. coli; type 025:86;
Sigma-Aldrich) before stimulation with ATP (Sigma-Aldrich), MSU
(Enzo Life Sciences, Farmingdale, NY), crystalline silica (Min-U-Sil 5,
U.S. Silica, Berkeley Springs, WV), S. typhimurium (see supple-
mentary Materials and methods online), L. pneumophila (see
supplementary Materials and methods online; [26]), or transfect-
ion with synthetic c-diGMP or c-diAMP (4 99% pure; [53]),
cGMP (Enzo Life Sciences), GTP (Sigma-Aldrich) or poly(dA:dT)
(Sigma-Aldrich), as indicated. Transfections were carried out with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) or X-tremeGENE
HP (Roche; Indianapolis, IN), respectively.
Immune assays. The level of IL-1b and caspase-1 in culture
supernatants was measured by immunoblotting with anti-IL-1b
(AF-401-NA; R&D System; Minneapolis, MN), anti-human-
caspase1 (06-503; Millipore; Billerica, MA), anti-murine-caspase1
(SC-514; Santa Cruz; Santa Cruz, CA; [32]), or by IL-1b ELISA
(BD Biosciences, San Jose, California).
Intraperitoneal injections. Control C57BL/6J, MPYS/STING[ / ]
or NLRP3[ / ] mice were injected (IP; 200 ml) with either
phosphate-buffered saline or c-diGMP (160 nmols). Cells were then
collected (350 g; 10 min; 4 1C) from the peritoneal lavage (2 5 ml
cold phosphate-buffered saline) of killed mice and evaluated by
fluorescence-activated cell sorting (F4/80, clone BM8, Biolegend,
San Diego, CA; and Ly6G, clone 1A8, BD Biosciences).
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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